isr

Sector Update: Healthcare

Healthcare stocks were mostly higher, with the NYSE Healthcare Sector Index rising 0.6% and shares of healthcare companies in the S&P 500 climbing 0.8% as a group.

In company news, IsoRay ( ISR ) shares were up more than 12% in recent trading Monday after state regulators in Washington cleared the company to produce its liquid Cesium-131 medical isotope.

The U.S. Food and Drug Administration previously approved Cesium-131, which is marketed under the Cesitrex brand name, to treat metastatic and glioblastoma brain tumors using GliaSite balloon catheters.

In a statement, ISR said it believes Cesium-131 offers several advantages over existing technologies in treating brain cancers, including eliminating the need for a thyroid block that is required with Iodine-125 therapy. It also is safer for the patient and staff, with an easier cleanup compared with other isotopes should a spill occur, the company said.

ISR shares were ahead more than 9% at $2.51 apiece in recent trade, earlier topping out at $2.76 a share. The stock has a 52-week range of 44 cents to $3.77 a share, surging a whopping 387.6% in value over the past 12 months.

In other sector news,

(-) PHMD, (-2.3%) Q1 earnings of $0.23 per share trail analyst projections by $0.02. Revenue slides 12.4% compared to year-ago levels to $50.1 mln, missing the Capital IQ consensus by around $6 mln.

(-) INO, (-6.5%) Q1 net loss widens to $10 mln, or $0.05 per share, from $6.6 mln loss last year and trailing analyst expectations for a $0.04 per share net loss. Revenue rises 60% year over year to $2.4 mln, topping Street view by nearly $1 mln.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.